A population-based national estimate of the prevalence and risk factors associated with hypertension in Rwanda: Implications for prevention and control

BMC Public Health

Volumn 18, Issue 1, 2017, Pages

  Nahimana, Marie Rosette ^a   Nyandwi, Alypio ^b   Muhimpundu, Marie Aimee ^c   Olu, Olushayo ^a   Condo, Jeanine Umutesi ^c   Rusanganwa, Andre ^a   Koama, Jean Baptiste ^d   Ngoc, Candide Tran ^a   Gasherebuka, Jean Bosco ^a   Ota, Martin O ^e   Okeibunor, Joseph C ^e  

^a WHO Country Office Consultant   (Rwanda)

^b Ministry of Health   (Rwanda)

^c RWANDA BIOMEDICAL CENTER   (Rwanda)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e WHO REGIONAL OFFICE FOR AFRICA   (Congo)

Author keywords

Epidemiology; Hypertension; Non communicable diseases; Risk factors; Rwanda

Indexed keywords

ADULT; AGE; BODY MASS; COMPLICATION; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; DRINKING BEHAVIOR; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; RURAL POPULATION; RWANDA; SEX DIFFERENCE; STATISTICAL MODEL; URBAN POPULATION; YOUNG ADULT;

ADULT; AGE FACTORS; ALCOHOL DRINKING; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PREVALENCE; RISK FACTORS; RURAL POPULATION; RWANDA; SEX FACTORS; SURVEYS AND QUESTIONNAIRES; URBAN POPULATION; YOUNG ADULT;

EID: 85022175998     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-017-4536-9     Document Type: Article

References (72)

1. Danaei G. Lu Y. Singh GM. Carnahan E. Stevens GA. Cowan MJ et al. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010. Lancet Diabetes and Endocrinol. 2014; 2(8):634-47. oi: 10.1016/S2213-8587(14)70102-0.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2013;380(9859):2224-60.
3. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. 2009. http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisks-report-full.pdf. Accessed 19 Dec 2016.
4. Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012;12(1):1. doi: 10.1186/1471-2377-12-117.
5. Mukhopadhyay J, Biswas M, Bhowmik J. Hypertension and Atherosclerosis-The Cardiovascular Risk Continuum. Medicine Update. 2011:41-5. Available from http://www.apiindia.org/ Accessed 19 Dec 2016.
6. McAloon CJ, Boylan LM, Hamborg T, Stallard N, Osman F, Lim PB, et al. The changing face of cardiovascular disease 2000-2012: an analysis of the world health organisation global health estimates data. Int J Cardiol. 2016 Dec 1;224:256-64.
7. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-Saharan Africa: a systematic review and meta-analysis. Hypertens. 2015;65(2):291-8. doi: 10.1161/HYPERTENSIONAHA.114.04394.
8. World Health Organization. Global status report on non-communicable diseases.2010. www.who.int/nmh/publications/ncd-report-full-en.pdf. Accessed 19 Dec 2016.
9. World Health Organization. STEPS country reports. 2015. http://www.who.int/chp/steps/reports/en/. Accessed 19 Dec 2016.
10. Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis. PLoS One. 2014;9(8):e104300. doi: 10.1371/journal.pone.0104300.
11. Aballay LR, Eynard AR, del Pilar Díaz M, Navarro A, Muñoz SE. Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutri Rev. 2013;71(3):168-79. doi: 10.1111/j.1753-4887.2012.00533.x.
12. Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hyperten Reps. 2013;15(3):134-6. doi: 10.1007/s11906-013-0340-9.
13. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circ. 2001;104(22):2746-53.
14. Ministry of Health. Rwanda Health Statistics booklet 2009-2014. http/ www.moh.gov.rw. Accessed 19 Dec 2016.
15. National Institute of Statistics of Rwanda Fourth Population and Housing Census, Rwanda, 2012. Available from http://www.statistics.gov.rw/. Accessed 19 Dec 2016.
16. de Ramirez SS, Enquobahrie DA, Nyadzi G, Mjungu D, Magombo F, Ramirez M, et al. Prevalence and correlates of hypertension: a cross-sectional study among rural populations in sub-Saharan Africa. J Hum Hypertens. 2010 Dec 1;24(12):786-95. doi: 10.1038/jhh.2010.14.
17. Banyangiriki J, Phillips J. Prevalence of hypertension among working adults in Rwanda. Iranian J Publ Health, Vol. 42, No.8, Aug 2013, pp.925-926. Available at: http://ijph.tums.ac.ir
18. Kamali P, Page C, Kagame A. Quality of blood pressure control in hypertensive patients attending the Kigali University teaching hospital (CHUK). Annals of Global Health. 2016 May 1;82(3):427.
19. Pande R, NIYONZIMA JP. Prevalence and clinical features of arterial hypertension in Ruhengeri District hospital, Musanze. Rwanda Rwanda Medical Journal. 2013 May 30;69(2):9-13.
20. World Health Organization. World Health rankings Live Longer Live Better 2016. www.worldlifeexpectancy.com/world-health-rankings. Accessed 19 Dec 2016.
21. Rwanda Non-communicable Diseases Risk Factors Report, MOH 2015. http://www.who.int/chp/steps/Rwanda-2012-STEPS-Report.pdf. Accessed 19 Dec 2016.
22. World Health Organization. The WHO STEPwise approach to non-communicable disease risk factor surveillance. http://www.who.int/chp/steps/manual/en/. Accessed 19 Dec 2016.
23. Alam M, Sumy SA, Parh YA. Selection of the Samples with Probability Proportional to Size. Science Journal of Applied Mathematics and Statistics. Vol. 3, No. 5, 2015, pp. 230-233.doi: 10.11648/j.sjams.20150305.13
24. Nemeth R. Respondent selection within the household-A modification of the Kish grid. In Meeting of Young Statisticians 2002 (p. 51).
25. Rizzo L, Brick JM, Park I. Minimally intrusive methods for sampling persons in random digit dial surveys. Public Opin Q. 2004; Jun 1;68(2):267-74.
26. Kumar RV. Respondent selection methods in household surveys. Jharkhand Journal of development and management studies. Available at SSRN. https://ssrn.com/abstract=2392928
27. World Health Organization. Clinical guidelines for the management of hypertension. 2005.
28. Kenya stepwise survey for non-communicable diseases risk factors 2015 report [INTERNET]: Ministry of Health. Available from www.health.go.ke/wp-content/uploads/2016/04/Executive-summary-6-2.pdf
29. World Health Organization. Global database on body mass index. 2006 [internet]. Available from apps.who.int /bmi/index.jsp?introPage=intro-3.html.
30. Plüddemann A, Thompson M, Price CP, Wolstenholme J, Heneghan C. Point-of-care testing for the analysis of lipid panels: primary care diagnostic technology update. Br J Gen Pract. 2012 Mar 1;62(596):e224-6.
31. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Available from http://www.who.int/diabetes/publications
32. Khanam MA, Lindeboom W, Razzaque A, Niessen L, Milton AH. Prevalence and determinants of pre-hypertension and hypertension among the adults in rural Bangladesh: findings from a community-based study. BMC Public Health. 2015;15(1):1. doi: 10.1186/s12889-015-1520-0.
33. Iwelunmor J, Airhihenbuwa CO, Cooper R, Tayo B, Plange-Rhule J, Adanu R, et al. Prevalence, determinants and systems-thinking approaches to optimal hypertension control in West Africa. Global Health. 2014;10(1):1. doi: 10.1186/1744-8603-10-42.
34. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013;62(1):18-26. doi: 10.1161/HYPERTENSIONAHA.113.01374.
35. Bjertness MB, Htet AS, Meyer HE, Htike MM, Zaw KK, Oo WM, et al. Prevalence and determinants of hypertension in Myanmar-a nationwide cross-sectional study. BMC Public Health. 2016;16(1):590. doi: 10.1186/s12889-016-3275-7.
36. Rani R, Mengi V, Gupta RK, Sharma HK. Hypertension and its risk factors-a cross sectional study in an urban population of a north Indian District. Public Health Research. 2015;5(3):67-72.
37. Goma M, Nzala H, Babaniyi O, Songolo P, Cosmos Z, Rudatsikira E, et al. Prevalence of hypertension and its correlates in Lusaka urban district of Zambia: a population based survey. Int Arch Med. 2011;4(1):34. doi: 10.1186/1755-7682-4-34.
38. Adediran O, Akintunde AA, Edo AE, Opadijo OG, Araoye AM. Impact of urbanization and gender on frequency of metabolic syndrome among native Abuja settlers in Nigeria. J Cardiovasc Dis Res. 2012 Sep 30;3(3):191-6. doi: 10.4103/0975-3583.98890.
39. Sliwa K, Acquah L, Gersh BJ, Mocumbi AO. Impact of socioeconomic status, ethnicity, and urbanization on risk factor profiles of cardiovascular disease in Africa. Circulation. 2016;133(12):1199-208. doi: 10.1161/circulationaha.114.008730.
40. Mohan I, Gupta R, Misra A, Sharma KK, Agrawal A, Vikram NK, et al. Disparities in prevalence of Cardiometablic risk factors in rural, urban-poor, and urban-middle class women in India. PLoS One. 2016 Feb 16;11(2):e0149437. doi: 10.1371/journal.pone.0149437.
41. Peter LS, John B, Nadia M, Shah E, Somnath C. Hypertension among older adults in low and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014:1-13. doi: 10.1093/ije/dyt215.
42. Omboni S, Carabelli G, Ghirardi E, Carugo S. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign. Vas Health and Risk Manag. 2013;9:177. doi: 10.2147/VHRM.S40925.
43. Ordunez P, Martinez R, Niebylski ML, Campbell NR. Hypertension prevention and control in Latin America and the Caribbean. J Clin Hyper. 2015 Jul 1;17(7):499-502.
44. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; Sep 4;310(9):959-68.
45. Irazola VE, Gutierrez L, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gaziano T, et al. Hypertension prevalence, awareness, treatment, and control in selected LMIC communities: results from the NHLBI/UHG network of Centers of excellence for chronic diseases. Glob Heart. 2016;11(1):47-59. doi: 10.1016/j.gheart.2015.12.008.
46. Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013 Aug 1;3(8):e003423.
47. Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11. J Hum Hypertens. 2015 Apr 1;29(4):247-53.
48. Jaramillo PL, Lopez PC, Alvarado L, Molina DI, Sanchez G, Arcos E, et al. Educational level influence in the prevalence, awareness, treatment and control of hypertension in Colombia. J Hypertens. 2015;33:e392-3.
49. Wang Y, Chen T, Wang K, Edwards CL. Education as an important risk factor for the prevalence of hypertension and elevated blood pressure in Chinese men and women. J Hum Hypertens. 2006;20(11):898-900. doi: 10.1038/sj.jhh.1002086.
50. Morenoff JD, House JS, Hansen BB, Williams DR, Kaplan GA, Hunte HE. Understanding social disparities in hypertension prevalence, awareness, treatment, and control: the role of neighborhood context. Social Sci Med. 2007;65(9):1853-66.
51. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26 913 adults in the Greek EPIC study. Int J Epidemiol. 2004 Dec 1;33(6):1345-52.
52. Khatib R, Schwalm JD, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9(1):e84238. doi: 10.1371/journal.pone.0084238.
53. Prezio EA, Cheng D, Balasubramanian BA, Shuval K, Kendzor DE, Culica D. Community diabetes education (CoDE) for uninsured Mexican Americans: a randomized controlled trial of a culturally tailored diabetes education and management program led by a community health worker. Diab Res Clin Pract. 2013;100(1):19-28. doi: 10.1016/j.diabres.2013.01.027.
54. Samal D, Greisenegger S, Auff E, Lang W, Lalouschek W. The relation between knowledge about hypertension and education in hospitalized patients with stroke in Vienna. Stroke. 2007;38(4):1304-8. doi: 10.1161/01.STR.0000259733.43470.27.
55. Mohan V, Seedat YK, Pradeepa R. The rising burden of diabetes and hypertension in southeast Asian and African regions: need for effective strategies for prevention and control in primary health care settings. Int J Hypertens. 2013; doi: 10.1155/2013/409083.
56. Nyarko SH. Prevalence and sociodemographic determinants of hypertension history among women in reproductive age in Ghana. Int J Hypertens. 2016 Apr;20:2016.
57. Vargas CM, Ingram DD, Gillum RF. Incidence of hypertension and Educational attainment the NHANES I epidemiologic Followup study. Am J Epidemiol. 2000 Aug 1;152(3):272-8.
58. Tedesco MA, Di Salvo G, Caputo S, Natale F, Ratti G, Iarussi D, et al. Educational level and hypertension: how socioeconomic differences condition health care. J Hum Hypertens. 2001 Oct 1;15(10):727.
59. Kavishe B, Biraro S, Baisley K, Vanobberghen F, Kapiga S, Munderi P, et al. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in northwestern Tanzania and southern Uganda. BMC Med. 2015;13(1):1. doi: 10.1186/s12916-015-0357-9.
60. Schneider RH, Grim CE, Rainforth MV, Kotchen T, Nidich SI, Gaylord-King C, et al. Stress reduction in the secondary prevention of cardiovascular disease randomized, controlled trial of transcendental meditation and health education in blacks. Circ Cardiovas Qual Outcomes. 2012;5(6):750-8. doi: 10.1161/CIRCOUTCOMES.112.967406.
61. Schwandt HM, Coresh J, Hindin MJ. Marital status, hypertension, coronary heart disease, diabetes, and death among African American women and men: incidence and prevalence in the atherosclerosis risk in communities (ARIC) study participants. J Fam Issues. 2010;31(9):1211-29. doi: 10.1177/0192513X10365487.
62. Wang H. Effects of marital status and transition on hypertension in Chinese women: a longitudinal study. [Unpublished] 2005. Presented at the 2005 Annual Meeting of the Population Association of America Philadelphia Pennsylvania March 31-April 2 2005.
63. Shabir D, Sajad H, Rafiq M, Ashfaq. The role of gender and their marital status in the Prevalance of hypertension in Kashmiri population. Scholars J Appl Med Sci. 2013;1(6):975-80.
64. Mohan I, Gupta R, Misra A, Sharma KK, Agrawal A, Vikram NK, et al. Disparities in prevalence of Cardiometablic risk factors in rural, urban-poor, and urban-middle class women in India. PLoS One. 2016; Feb 16;11(2):e0149437. doi: 10.1371/journal.pone.0149437.
65. Ekezie J, Anyanwu EG, Danborno B, Anthony U. Impact of urbanization on obesity, anthropometric profile and blood pressure in the Igbos of Nigeria. N Am J Med Sci. 2011;3(5):242. doi: 10.4297/najms.2011.3242.
66. Attard SM, Herring AH, Zhang B, Du S, Popkin BM, Gordon-Larsen P. Associations between age, cohort, and urbanization with systolic and diastolic blood pressure in China: a population-based study across 18 years. J Hypertens. 2015;33(5):948-56. doi: 10.1097/HJH.0000000000000522.
67. Bhansali A, Dhandania VK, Deepa M, Anjana RM, Joshi SR, Joshi PP, et al. Prevalence of and risk factors for hypertension in urban and rural India: the ICMR-INDIAB study. J Hum Hypertens. 2015;29(3):204-9. doi: 10.1038/jhh.2014.57.
68. Mathenge W, Foster A, Kuper H. Urbanization, ethnicity and cardiovascular risk in a population in transition in Nakuru, Kenya: a population-based survey. BMC Public Health. 2010;10(1):1. doi: 10.1186/1471-2458-10-569.
69. Do HT, Geleijnse JM, Le MB, Kok FJ, Feskens EJ. National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults. Am J Hypertens. 2015 Jan 1;28(1):89-97.
70. Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J, et al. Prevalence of hypertension in China: a cross-sectional study. PLoS One. 2013 Jun 11;8(6):e65938.
71. Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S. Hypertension among older adults in low-and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014 Feb 1;43(1):116-28.
72. Modesti PA, Bamoshmoosh M, Rapi S, Massetti L, Al-Hidabi D, Al GH. Epidemiology of hypertension in Yemen: effects of urbanization and geographical area. Hypertens Res. 2013;36(8):711-7. doi: 10.1038/hr.2013.